Univariate analysis |
Albumin < 35 g/l |
0.849 |
0.527–1.367 |
0.500 |
β2‐Microglobulin >5.5 g/l |
2.146 |
1.340–3.436 |
0.001 |
ISS Stage (I vs. II vs. III) |
1.554 |
1.177–2.051 |
0.002 |
Creatinine >2 mg/dl |
1.115 |
0.485–2.560 |
0.798 |
LDH > 250 U/l |
1.538 |
0.794–2.981 |
0.202 |
Response ≥ VGPR |
1.757 |
1.147–2.692 |
0.010 |
Hemoglobin ≤ 10 g/dl |
1.864 |
1.059–3.282 |
0.031 |
Calcium > 10.5 mg/dl (>2.6 mmol/l) |
3.239 |
1.599–6.559 |
0.001 |
FLC ratio <0.03 or >32 |
1.018 |
0.677–1.531 |
0.932 |
HLC ratio <0.022 or > 45 |
1.712 |
1.135–2.583 |
0.010 |
HLC matched pair suppression <LLN |
0.826 |
0.468–1.460 |
0.508 |
HLC matched pair suppression >50% |
1.581 |
1.026–2.434 |
0.038 |
Noninvolved isotype suppression <LLN |
0.994 |
0.754–1.312 |
0.981 |
Noninvolved isotype suppression >50% |
0.932 |
0.729–1.193 |
0.811 |
Risk of FISH cytogenetics (90 patients) |
2.131 |
1.189–3.819 |
0.009 |
Multivariate analysis |
β2‐Microglobulin >5.5 g/l |
1.389 |
0.669–2.884 |
0.378 |
ISS stage (I vs. II vs. III) |
1.526 |
0.890–2.614 |
0.124 |
Response > VGPR |
1.853 |
1.140–3.012 |
0.013 |
Hemoglobin > 10 g/dl |
1.502 |
0.760–2.967 |
0.242 |
Calcium > 10.5 mg/dl (>2.6 mmol/l) |
2.460 |
0.997–6.068 |
0.051 |
HLC ratio <0.022 or > 45 |
1.721 |
0.885–3.345 |
0.110 |
HLC matched pair suppression >50% |
2.553 |
1.214–5.367 |
0.013 |